SCHEMBL7374155

SCHEMBL7374155

Cc1csc(-c2nc3n(c2-c2ccncc2)CCS3)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 10/20 0.60
MAPK13 O15264 2/20 0.60
MAPK12 P53778 2/20 0.60
MAPK11 Q15759 2/20 0.60
KDM4E B2RXH2 3/20 0.59
TDP1 Q9NUW8 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
CYP3A4 P08684 1/20 0.59
HPGD P15428 1/20 0.59
ALOX15 P16050 1/20 0.59
HSD17B10 Q99714 1/20 0.59
TGFBR1 P36897 1/20 0.45
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
ALDH1A1 P00352 3/20 0.35
MAPT P10636 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9297762 0.93 MAPK14 (0.52) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL7369798 0.90 MAPK14 (0.60) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL11502671 0.83 MAPK14 (0.76) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL9298106 0.83 TGFBR1 (0.43) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL9436245 0.82 MAPK14 (0.84) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL7352500 0.80 PDE10A (0.51) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL9700106 0.79 PDE10A (0.47) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL9195358 0.78 GABRA1 (0.42) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL9748155 0.78 MAPK14 (0.76) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL9197222 0.76 GABRA1 (0.36) MAPK14MAPK13MAPK12MAPK11KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1990015534-A1 MONOKINE ACTIVITY INTERFERENCE SMITHKLINE BEECHAM CORPORATION (US) 1990-12-27 WO claimed
EP-0321490-B1 INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES SMITHKLINE BEECHAM CORP (US) 1994-06-22 EP disclosed
US-5317019-A Antiinflammatory agents SMITHKLINE BEECHAM CORP. (US) 1994-05-31 US disclosed
EP-0411754-A2 Medicament for the inhibition of interleukin-1 or tumor necrosis factor production by monocytes and/or macrophages SMITHKLINE BEECHAM CORPORATION (US) 1991-02-06 EP disclosed
WO-1991000092-A1 INHIBITION OF INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR PRODUCTION BY MONOCYTES AND/OR MACROPHAGES SMITHKLINE BEECHAM CORPORATION (US) 1991-01-10 WO disclosed
WO-1990015534-A1 MONOKINE ACTIVITY INTERFERENCE SMITHKLINE BEECHAM CORPORATION (US) 1990-12-27 WO disclosed
EP-0403251-A2 Monokine activity interference SMITHKLINE BEECHAM CORPORATION (US) 1990-12-19 EP disclosed
EP-0321490-A4 INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES. SMITHKLINE BECKMAN CORP (US) 1990-05-14 EP disclosed
EP-0321490-A1 INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES. SMITHKLINE BECKMAN CORP (US) 1989-06-28 EP disclosed
WO-1988001169-A1 INHIBITION OF INTERLEUKIN-1 PRODUCTION BY MONOCYTES AND/OR MACROPHAGES SMITHKLINE BECKMAN CORPORATION (US) 1988-02-25 WO disclosed
US-4175127-A ANTIARTHRITIC AGENTS SMITHKLINE CORPORATION (US) 1979-11-20 US disclosed